A new immunotherapy for treating stomach cancer is helping people live 40% longer. However, some are affected by this ...

Gastroesophageal junction adenocarcinoma is a rare type of cancer of the esophagus, the tube that connects your mouth and stomach. It starts in the gastroesophageal (GE) junction, the area where ...

When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

The meeting point of the stomach and esophagus, the so-called gastro-esophageal junction, is a region of the human body that is not well-suited to the modern lifestyle. Stress, alcohol ...

This occurs due to changes in the glandular cells that exist at the junction of the esophagus and the stomach. Rarer types include: choriocarcinoma lymphoma melanoma sarcoma small cell cancer The ...

The meeting point of the stomach and esophagus, the so-called gastro-esophageal junction, is a region of the human body that is not well-suited to the modern lifestyle. Stress, alcohol ...

near the junction with the stomach. It’s the most common form of esophageal cancer in the United States. Squamous cell carcinoma is the most common esophageal cancer worldwide and is more common ...

Immunotherapy combined with chemo can give people a fighting chance against stomach and esophageal cancers, a new clinical ...

Reduced reflux risk: Left-side sleeping helps keep the junction between stomach and esophagus above the level of stomach acid, reducing reflux risk. Enhanced waste movement: This position promotes ...

Credit: Astellas. Vyloy is a claudin 18.2-directed cytolytic antibody. In clinical trials, CLDN18.2 positivity was determined by immunohistochemistry on gastric or GEJ tumor tissue specimens with ...

Tevimbra is also indicated for the treatment of adult patients with unresectable or metastatic esophageal squamous cell carcinoma after prior systemic chemotherapy that did not include a PD-L1 ...